UNH Unitedhealth

UnitedHealth Group Incorporated is an American for-profit managed health care company based in Minnetonka, Minnesota. It offers health care products and insurance services. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. UnitedHealthcare revenues comprise 80% of the Group's overall revenue. The company is ranked 7th on the 2020 Fortune 500.
Company profile
Ticker
UNH
Exchange
Website
CEO
David Wichmann
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Cigna • Cigna Holding • Anthem • Humana • WellCare Health Plans • Centene • Molina Healthcare • DCP Holding • Trupanion • Clover Health Investments ...
Former names
UNITED HEALTHCARE CORP
SEC CIK
Corporate docs
IRS number
411321939
UNH stock data
()
News
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
1 Mar 21
UnitedHealth Group: Q4 Earnings Insights
20 Jan 21
A Peek Into The Markets: US Stock Futures Up; Biden's Inauguration In Focus
20 Jan 21
5 Stocks To Watch For January 20, 2021
20 Jan 21
Earnings Scheduled For January 20, 2021
20 Jan 21
Press releases
UnitedHealthcare Children's Foundation Awards 25,000th Grant
24 Feb 21
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
24 Feb 21
Leading $2.8 Trillion US Healthcare Market: CEO's of Skylight Health, Oak Street, UnitedHealth Group, 1life Healthcare - Innovating Next Generation Healthcare Systems
17 Feb 21
CHANGE HEALTHCARE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Change Healthcare - CHNG
9 Feb 21
UnitedHealth Group Announces Executive Leadership Actions
4 Feb 21
Calendar
1 Mar 21
2 Mar 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 16.92B | 16.92B | 16.92B | 16.92B | 16.92B | 16.92B |
Cash burn (monthly) | 209.67M | (positive/no burn) | (positive/no burn) | (positive/no burn) | (positive/no burn) | (positive/no burn) |
Cash used (since last report) | 428.49M | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 16.49B | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 78.7 | n/a | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Feb 21 | John F Rex | Common Stock | Grant | Aquire A | No | No | 0 | 8,699 | 0 | 103,622.668 |
22 Feb 21 | John F Rex | Common Stock | Payment of exercise | Dispose F | No | No | 327.64 | 8,250 | 2.7M | 94,923.668 |
22 Feb 21 | John F Rex | Common Stock | Grant | Aquire A | No | No | 327.64 | 16,768 | 5.49M | 103,173.668 |
22 Feb 21 | John F Rex | NQSO Common Stock | Grant | Aquire A | No | No | 327.64 | 40,703 | 13.34M | 40,703 |
22 Feb 21 | Dirk C McMahon | Common Stock | Grant | Aquire A | No | No | 0 | 8,699 | 0 | 80,751.03 |
22 Feb 21 | Dirk C McMahon | Common Stock | Payment of exercise | Dispose F | No | No | 327.64 | 8,410 | 2.76M | 72,052.03 |
22 Feb 21 | Dirk C McMahon | Common Stock | Grant | Aquire A | No | No | 327.64 | 18,444 | 6.04M | 80,462.03 |
22 Feb 21 | Dirk C McMahon | NQSO Common Stock | Grant | Aquire A | No | No | 327.64 | 40,703 | 13.34M | 40,703 |
22 Feb 21 | Stephen J Hemsley | Common Stock | Payment of exercise | Dispose F | No | No | 327.64 | 13,785 | 4.52M | 977,622.019 |
22 Feb 21 | Stephen J Hemsley | Common Stock | Grant | Aquire A | No | No | 327.64 | 30,182 | 9.89M | 991,407.019 |
Institutional ownership Q4 2020
85.7% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 2289 |
Opened positions | 310 |
Closed positions | 157 |
Increased positions | 965 |
Reduced positions | 784 |
13F shares |
Current |
---|---|
Total value | 285.31B |
Total shares | 813.48M |
Total puts | 6.55M |
Total calls | 5.31M |
Total put/call ratio | 1.2 |
Largest owners |
Shares | Value |
---|---|---|
Vanguard | 79.09M | $27.74B |
BLK Blackrock | 71.59M | $25.11B |
FMR | 52.57M | $18.43B |
STT State Street | 44.23M | $15.51B |
TROW T. Rowe Price | 38M | $13.32B |
Capital World Investors | 35.19M | $12.34B |
Wellington Management | 33.78M | $11.85B |
Capital Research Global Investors | 21.96M | $7.7B |
Capital International Investors | 17.86M | $6.26B |
Geode Capital Management | 14.16M | $4.95B |
Financial report summary
?Risks
- We are subject to risks associated with public health crises, large-scale medical emergencies and pandemics, such as the COVID-19 pandemic, which could have a material adverse effect on our business, results of operations, financial condition and financial performance.
- If we fail to estimate, price for and manage our medical costs in an effective manner, the profitability of our risk-based products and services could decline and could materially and adversely affect our results of operations, financial position and cash flows.
- If we fail to maintain properly the integrity or availability of our data or successfully consolidate, integrate, upgrade or expand our existing information systems, or if our technology products do not operate as intended, our business could be materially and adversely affected.
- If we sustain cyber-attacks or other privacy or data security incidents resulting in security breaches disrupting our operations or resulting in the unintended dissemination of protected personal information or proprietary or confidential information, we could suffer a loss of revenue and increased costs, exposure to significant liability, reputational harm and other serious negative consequences.
- If we fail to develop and maintain satisfactory relationships with physicians, hospitals and other service providers, our business could be materially and adversely affected.
- We are routinely subject to various legal actions due to the nature of our business, which could damage our reputation and, if resolved unfavorably, could result in substantial penalties or monetary damages and materially and adversely affect our results of operations, financial position and cash flows.
- Any failure by us to manage successfully our strategic alliances or complete, manage or integrate acquisitions and other significant strategic transactions or relationships domestically or outside the United States could materially and adversely affect our business, prospects, results of operations, financial position and cash flows.
- Our sales performance will suffer if we do not adequately attract, retain and provide support to a network of independent producers and consultants.
- Unfavorable economic conditions could materially and adversely affect our revenues and our results of operations.
- Our failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect our business, results of operations and future performance.
- Our investment portfolio may suffer losses which could adversely affect our results of operations, financial position and cash flows.
- If the value of our intangible assets is materially impaired, our results of operations, equity and credit ratings could be materially and adversely affected.
- If we are not able to protect our proprietary rights to our databases, software and related products, our ability to market our knowledge and information-related businesses could be hindered and our results of operations, financial position and cash flows could be materially and adversely affected.
- Any downgrades in our credit ratings could adversely affect our business, financial condition and results of operations.
- Risks Related to the Regulation of Our Business
- Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.
- As a result of our participation in various government health care programs, both as a payer and as a service provider to payers, we are exposed to additional risks associated with program funding, enrollments, payment adjustments, audits and government investigations which could materially and adversely affect our business, results of operations, financial position and cash flows.
- Our businesses providing pharmacy care services face regulatory and operational risks and uncertainties which may differ from the risks of our other businesses.
- If we fail to comply with applicable privacy, security and data laws, regulations and standards, including with respect to third-party service providers utilizing protected personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.
- Restrictions on our ability to obtain funds from our regulated subsidiaries could materially and adversely affect our results of operations, financial position and cash flows.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absence, accessed, aerospace, aim, alleged, attrition, began, begun, belonging, biggest, bridging, broader, career, CHNG, coaching, compassion, complementary, concierge, curtail, cybersecurity, dannette, deep, defending, diligence, DuPont, easing, empower, empowerment, enterprise, Envoy, ethnicity, extremely, feedback, flat, guided, half, handling, hardship, heard, hiring, inclusion, inclusive, indictment, leader, leadership, Lear, liable, Lockheed, main, Martin, mentorship, metric, missed, mission, modestly, NASDAQ, Nonqualified, online, outreach, pandemic, Patricia, payoff, pipeline, prioritize, privileged, race, redetermination, restored, SCA, script, sense, simplified, situation, skill, skilled, smith, Stewardship, STOCKHOLDER, strive, Supreme, talent, team, telehealth, temporarily, therapeutic, today, transparent, Triple, unified, unprecedented, vaccine, vigorously, virtual, widespread, workforce
Removed:
AAA, Addendum, amid, attack, Ballard, budget, build, challenge, charitable, chiropractic, comparative, concluding, conversion, coordinating, corroborate, created, Delaware, demonstrate, deployed, Dorsey, eligibility, Ellen, emerging, endeavoring, epidemiology, excellence, Fidelity, focused, genetic, govern, head, healthy, hospitalization, imposition, improvement, inappropriately, indeterminable, ingredient, Initial, Jr, Letter, likelihood, limiting, marianne, military, MINE, neighborhood, Nelson, operated, organ, originally, par, procurement, put, replaced, retrospectively, revaluation, reward, scale, selling, shareholder, Steven, strategically, subjected, tailored, tenure, transplant, Whitney, Wilson, written
Financial reports
10-K
2020 FY
Annual report
1 Mar 21
10-Q
2020 Q3
Quarterly report
2 Nov 20
10-Q
2020 Q2
Quarterly report
2 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
14 Feb 20
10-Q
2019 Q3
Quarterly report
6 Nov 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
7 May 19
10-K
2018 FY
Annual report
12 Feb 19
10-Q
2018 Q3
Quarterly report
8 Nov 18
Current reports
8-K
Departure of Directors or Certain Officers
26 Feb 21
8-K
Departure of Directors or Certain Officers
8 Feb 21
8-K
Unitedhealth Group Reports Fourth Quarter and Full Year 2020 Results
20 Jan 21
8-K
Regulation FD Disclosure
6 Jan 21
8-K
Departure of Directors or Certain Officers
2 Dec 20
8-K
Unitedhealth Group Updates Business Outlook Ahead of Investor Conference
1 Dec 20
8-K
Unitedhealth Group to Host 2020 Investor Conference
25 Nov 20
8-K
Unitedhealth Group Names Matthew W. Friedrich Chief Legal Officer
20 Nov 20
8-K
Unitedhealth Group Reports Third Quarter Performance
14 Oct 20
8-K
Reports Second Quarter Performance
15 Jul 20
Registration and prospectus
S-8
Registration of securities for employees
1 Jun 20
424B5
Prospectus supplement for primary offering
14 May 20
FWP
Free writing prospectus
13 May 20
424B5
Prospectus supplement for primary offering
13 May 20
S-3ASR
Automatic shelf registration
24 Feb 20
S-8
Registration of securities for employees
10 Feb 20
SC TO-T/A
Third party tender offer statement (amended)
7 Feb 20
SC TO-T/A
Third party tender offer statement (amended)
29 Jan 20
SC TO-T/A
Third party tender offer statement (amended)
21 Jan 20
SC TO-T
Third party tender offer statement
9 Jan 20
Proxies
DFAN14A
Additional proxy materials by non-management
6 Jan 21
DEFA14A
Additional proxy soliciting materials
6 Jan 21
DEFA14A
Additional proxy soliciting materials
17 Apr 20
DEF 14A
Definitive proxy
17 Apr 20
DEFA14A
Additional proxy soliciting materials
19 Apr 19
DEF 14A
Definitive proxy
19 Apr 19
DEF 14A
Definitive proxy
19 Apr 18
DEFA14A
Additional proxy soliciting materials
19 Apr 18
DFAN14A
Additional proxy materials by non-management
30 Aug 17
DEFA14A
Additional proxy soliciting materials
28 Aug 17
Other
CORRESP
Correspondence with SEC
28 Jan 20
UPLOAD
Letter from SEC
10 Apr 18
EFFECT
Notice of effectiveness
3 Apr 17
EFFECT
Notice of effectiveness
21 Mar 17
CORRESP
Correspondence with SEC
19 Mar 17
CORRESP
Correspondence with SEC
2 Mar 17
NO ACT
No action letter
1 Mar 17
UPLOAD
Letter from SEC
27 Feb 17
NO ACT
No action letter
13 Feb 17
NO ACT
No action letter
9 Feb 17
Ownership
4
UNITEDHEALTH / ANDREW WITTY ownership change
24 Feb 21
4
UNITEDHEALTH / THOMAS E ROOS ownership change
24 Feb 21
4
UNITEDHEALTH / STEPHEN J HEMSLEY ownership change
24 Feb 21
4
UNITEDHEALTH / JOHN F REX ownership change
24 Feb 21
4
UNITEDHEALTH / Dirk C McMahon ownership change
24 Feb 21
4
UNITEDHEALTH / PATRICIA L LEWIS ownership change
23 Feb 21
4
UNITEDHEALTH / RICHARD T BURKE ownership change
22 Feb 21
4
UNITEDHEALTH / THOMAS E ROOS ownership change
17 Feb 21
4
UNITEDHEALTH / ANDREW WITTY ownership change
16 Feb 21
4
UNITEDHEALTH / THOMAS E ROOS ownership change
16 Feb 21
Patents
GRANT
Utility
Device for reducing fraud, waste, and abuse in the ordering and performance of medical testing and methods for using the same
23 Feb 21
Provided is a lab clearinghouse device configured to reduce fraud, waste, and abuse in the ordering and performance of medical testing.
APP
Utility
Predictive Data Analysis In Conceptually Hierarchical Domains
18 Feb 21
There is a need for solutions for more effective and efficient predictive data analysis systems in conceptually hierarchical domains.
APP
Utility
Mere-parsing with Boundary and Semantic Driven Scoping
11 Feb 21
Methods, systems and computer program products for implementing a mere-parser are disclosed.
APP
Utility
Data Validation And/or Data Conversion Using Smart Contracts In Distributed Ledger Systems
4 Feb 21
Computer program products, methods, systems, apparatus, and computing entities are provided for automatically validating and/or converting data in candidate transaction in a distributed ledger systems.
APP
Utility
Apparatus and Method for Improved Network Data Security Enforcement and Verification
28 Jan 21
An apparatus, method, and computer program product for the improved identification of files subject to data loss prevention protocols in a network environment.
Transcripts
2020 Q4
Earnings call transcript
20 Jan 21
2020 Q3
Earnings call transcript
14 Oct 20
2020 Q2
Earnings call transcript
15 Jul 20
2020 Q1
Earnings call transcript
15 Apr 20
2019 Q4
Earnings call transcript
15 Jan 20
2019 Q3
Earnings call transcript
15 Oct 19
2019 Q2
Earnings call transcript
18 Jul 19
2019 Q1
Earnings call transcript
16 Apr 19
2018 Q4
Earnings call transcript
15 Jan 19
2018 Q3
Earnings call transcript
16 Oct 18
Reddit threads
Why it is usually a mistake for investors to take profits
1 Mar 21
My biggest take away from every Amazon and Tesla post.
28 Feb 21
What are some of the best dividend stocks with great growth?
28 Feb 21
Bluechip still worth?
26 Feb 21
What additional stock should I pick up?
24 Feb 21
Daily General Discussion and spitballin thread
23 Feb 21
Down 9k on GME but I’m ready for round 2 🚀🚀
20 Feb 21
FMR [7]: UnitedHealth ($UNH) DD: ATM or ITM Call EXP 4/16
20 Feb 21
Vlad's testimony in a nutshell
19 Feb 21
stocks I like - for the hedge funds buying tech to track this
19 Feb 21